Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

And even if Judgement Day teammate Liv Morgan lost her women’s world title during WWE’s premiere episode of Raw on Netflix ...

WWE Superstar Raquel Rodriguez recently broke character to provide a rare health update. The veteran is currently aligned with Liv Morgan and The Judgment Day on WWE RAW.

Love word games? Try BONGO, the new daily challenge designed by celebs & leaders.

AYVAKIT's multibillion-dollar potential and BLU-808 breakthroughs drive BPMC's meteoric rise in biotech innovation.

Postmedia’s Rob Wong chats with Postmedia wrestling writer Jan Murphy chat with WWE Superstar Raquel Rodriguez about her impressions of the RAW on Netflix era, her journey to becoming a professional ...

Wedbush lowered the firm’s price target on Blueprint Medicines (BPMC) to $124 from $135 and keeps an Outperform rating on the shares. The firm ...

Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin. Maurer was an author ...

Morgan Stanley analyst Michael Ulz has maintained their neutral stance on BPMC stock, giving a Hold rating on January 9.Stay Ahead of the ...

Common types in senior dogs include mast cell tumors, lymphoma, hemangiosarcoma, squamous cell carcinoma, oral melanomas, and ...

Shares of Blueprint Medicines rose after the company said its flagship drug Ayvakit could bring in $2 billion in revenue by 2030. Shares were recently up 14%, to $99.70, midday Monday. The stock is up ...

Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement ...